# Twist Bioscience Corp: filings

TWST · Nasdaq · CIK 1581280 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/twst.md) · [Financials](/companies/twst/financials.md) · [Filings](/companies/twst/filings.md) · [Insiders](/companies/twst/insiders.md)

## Reports and events: 128 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 956, 144 335, 8-K 78, 3 27, SC 13G/A 27, 10-Q 24, 4/A 22, SCHEDULE 13G/A 19, SC 13G 13, 424B5 11, CORRESP 9, S-8 9, 10-K 8, DEF 14A 8, D 7, UPLOAD 7, SCHEDULE 13G 5, 424B7 4, D/A 4, DRS/A 4, 8-K/A 3, ARS 3, EFFECT 3, S-1/A 3, S-3ASR 3, 424B4 2, DRS 2, DRSLTR 2, S-1 2, 10-K/A 1, 10-Q/A 1, 144/A 1, 3/A 1, 8-A12B 1, CERT 1, CT ORDER 1, PRE 14A 1, S-1MEF 1, S-3 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-19 | 17:24 ET | [8-K](/filings/0001104659-26-098830.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-098830 |
| 2026-08-19 | 18:15 ET | [8-K](/filings/0001581280-26-000050.md) | 7.01 Regulation FD disclosure | 0001581280-26-000050 |
| 2026-08-05 | 17:27 ET | [8-K](/filings/0001104659-26-091280.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-091280 |
| 2026-08-03 | 16:10 ET | [10-Q](/filings/0001581280-26-000047.md) | Quarterly report, period 2026-06-30 | 0001581280-26-000047 |
| 2026-08-03 | 07:21 ET | [8-K](/filings/0001581280-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001581280-26-000044 |
| 2026-05-04 | 16:28 ET | [10-Q](/filings/0001581280-26-000040.md) | Quarterly report, period 2026-03-31 | 0001581280-26-000040 |
| 2026-05-04 | 07:21 ET | [8-K](/filings/0001581280-26-000037.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001581280-26-000037 |
| 2026-02-26 | 16:19 ET | [10-Q/A](/filings/0001581280-26-000029.md) | Quarterly report, amended, period 2025-12-31 | 0001581280-26-000029 |
| 2026-02-17 | 07:09 ET | [8-K](/filings/0001104659-26-015730.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-015730 |
| 2026-02-06 | 17:25 ET | [8-K](/filings/0001581280-26-000022.md) | 5.07 Shareholder vote results | 0001581280-26-000022 |
| 2026-02-02 | 16:15 ET | [10-Q](/filings/0001581280-26-000019.md) | Quarterly report, period 2025-12-31 | 0001581280-26-000019 |
| 2026-02-02 | 07:20 ET | [8-K](/filings/0001581280-26-000016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001581280-26-000016 |
| 2026-01-12 | 08:13 ET | [8-K](/filings/0001581280-26-000012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001581280-26-000012 |
| 2026-01-06 | 16:13 ET | [DEF 14A](/filings/0001581280-26-000006.md) | Proxy statement, period 2026-02-05 | 0001581280-26-000006 |
| 2025-11-17 | 07:31 ET | [10-K](/filings/0001581280-25-000025.md) | Annual report, period 2025-09-30 | 0001581280-25-000025 |
| 2025-11-14 | 07:21 ET | [8-K](/filings/0001581280-25-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001581280-25-000020 |
| 2025-08-06 | 16:05 ET | [8-K](/filings/0001581280-25-000012.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001581280-25-000012 |
| 2025-08-04 | 16:24 ET | [10-Q](/filings/0001581280-25-000009.md) | Quarterly report, period 2025-06-30 | 0001581280-25-000009 |
| 2025-08-04 | 07:21 ET | [8-K](/filings/0001581280-25-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001581280-25-000006 |
| 2025-05-05 | 16:05 ET | [10-Q](/filings/0001628280-25-022154.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022154 |
| 2025-05-05 | 07:27 ET | [8-K](/filings/0001104659-25-044352.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-044352 |
| 2025-02-11 | 17:00 ET | [8-K](/filings/0001104659-25-011543.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-011543 |
| 2025-02-03 | 16:09 ET | [10-Q](/filings/0001628280-25-003461.md) | Quarterly report, period 2024-12-31 | 0001628280-25-003461 |
| 2025-02-03 | 07:18 ET | [8-K](/filings/0001628280-25-003387.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-003387 |
| 2025-01-06 | 17:24 ET | [DEF 14A](/filings/0001628280-25-000641.md) | Proxy statement, period 2025-01-06 | 0001628280-25-000641 |
| 2024-11-18 | 16:10 ET | [10-K](/filings/0001628280-24-048262.md) | Annual report, period 2024-09-30 | 0001628280-24-048262 |
| 2024-11-18 | 07:20 ET | [8-K](/filings/0001628280-24-048173.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-048173 |
| 2024-10-15 | 16:16 ET | [8-K](/filings/0001104659-24-108591.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-108591 |
| 2024-08-02 | 16:24 ET | [10-Q](/filings/0001628280-24-034434.md) | Quarterly report, period 2024-06-30 | 0001628280-24-034434 |
| 2024-08-02 | 07:33 ET | [8-K](/filings/0001628280-24-034277.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034277 |
| 2024-05-02 | 16:13 ET | [10-Q](/filings/0001628280-24-020014.md) | Quarterly report, period 2024-03-31 | 0001628280-24-020014 |
| 2024-05-02 | 16:07 ET | [8-K](/filings/0001628280-24-019999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-019999 |
| 2024-02-07 | 16:05 ET | [8-K](/filings/0001104659-24-011607.md) | 5.07 Shareholder vote results | 0001104659-24-011607 |
| 2024-02-02 | 16:04 ET | [10-Q](/filings/0001628280-24-003051.md) | Quarterly report, period 2023-12-31 | 0001628280-24-003051 |
| 2024-02-02 | 07:32 ET | [8-K](/filings/0001628280-24-002998.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-002998 |
| 2024-01-05 | 16:02 ET | [DEF 14A](/filings/0001628280-24-000650.md) | Proxy statement, period 2024-02-06 | 0001628280-24-000650 |
| 2024-01-05 | 08:08 ET | [8-K](/filings/0001104659-24-001628.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-001628 |
| 2023-11-21 | 16:03 ET | [10-K](/filings/0001628280-23-039767.md) | Annual report, period 2023-09-30 | 0001628280-23-039767 |
| 2023-11-17 | 07:32 ET | [8-K](/filings/0001628280-23-039394.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-039394 |
| 2023-08-07 | 16:34 ET | [10-Q](/filings/0001628280-23-027803.md) | Quarterly report, period 2023-06-30 | 0001628280-23-027803 |
| 2023-08-04 | 07:32 ET | [8-K](/filings/0001628280-23-027406.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-027406 |
| 2023-08-04 | 07:25 ET | [8-K/A](/filings/0001104659-23-087548.md) | 2.05 Exit or disposal costs | 0001104659-23-087548 |
| 2023-06-05 | 16:31 ET | [10-K/A](/filings/0001628280-23-020881.md) | Annual report, amended, period 2022-09-30 | 0001628280-23-020881 |
| 2023-05-23 | 08:04 ET | [8-K](/filings/0001104659-23-063421.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-063421 |
| 2023-05-08 | 16:19 ET | [10-Q](/filings/0001628280-23-016426.md) | Quarterly report, period 2023-03-31 | 0001628280-23-016426 |
| 2023-05-05 | 07:33 ET | [8-K](/filings/0001628280-23-015988.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-23-015988 |
| 2023-03-28 | 06:31 ET | [8-K](/filings/0001104659-23-037343.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-037343 |
| 2023-02-08 | 16:00 ET | [8-K](/filings/0001104659-23-014513.md) | 5.07 Shareholder vote results | 0001104659-23-014513 |
| 2023-02-07 | 16:12 ET | [10-Q](/filings/0001628280-23-002560.md) | Quarterly report, period 2022-12-31 | 0001628280-23-002560 |
| 2023-02-03 | 07:32 ET | [8-K](/filings/0001628280-23-002145.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-002145 |

Page 1 of 3. [Older](/companies/twst/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:07 ET. No prices; not investment advice.